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Abstract: 
We have constructed a phage-displayed library based on the human fibronectin tenth type III 
domain (FN3) scaffold by randomizing residues in its FG and BC loops. Screening against the 
SH3 domain of human c-Src yielded six different clones. Five of these contained proline-rich 
sequences in their FG loop that resembled class I (i.e., +xxPxxP) peptide ligands for the Src SH3 
domain. The sixth clone lacked the proline-rich sequence and showed particularly high binding 
specificity to the Src SH3 domain among various SH3 domains tested. Competitive binding, loop 
replacement, and NMR perturbation experiments were conducted to analyze the recognition 
properties of selected binders. The strongest binder was able to pull down full-length c-Src from 
murine fibroblast cell extracts, further demonstrating the potential of this scaffold for use as an 
antibody mimetic
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Added in Proof), and the tenth type III domain of human
fibronectin (FN3) [5].
Of these, FN3 is a monomeric, 94 residue domain,
with an immunoglobulin-like fold formed by seven anti-
parallel  strands (Figure 1). The strands (A, B, C, D, E,
F, and G) are connected by three loops on each side of
the protein (i.e., loops BC, DE, and FG on one side and
loops AB, CD, and EF on the opposite side). All of the
loops, except the EF loop, have been shown to tolerate
insertions of four glycine residues with little destabiliza-
tion [6], demonstrating that five of the loops can be used
as sites for grafting and/or randomization of residues.
FN3 is an excellent candidate as an antibody mimetic
because of its small size, high solubility, thermal stability
[7], and lack of disulfide bonds, which permits intracellu-
lar expression [8]. The first FN3 library randomized five
residues in each of the BC and FG loops and shortened
the FG loop by three residues to give the protein a more
planar binding surface [5]. Selection experiments using
this M13 bacteriophage-displayed library yielded rela-
tively modest affinity binders to ubiquitin (IC50  5 M),
although these also crossreacted with dextran. The po-
tential of this scaffold was later explored in a yeast two-
hybrid system, in which seven residues in the FG or the
AB loop were randomized and clones were selected for
their ability to bind the estrogen receptor  ligand bind-
ing domain [8]. Interestingly, the screen yielded confor-
mation-specific binders for the agonist- or antagonist-
bound forms of the receptor. Finally, an mRNA display
library of greater than 1012 individual clones was created
by randomizing a total of 21 residues in the BC, DE, and
FG loops [9]. A large number of high-affinity binders for
TNF- with Kd values between 1–24 nM were obtained
from this library, further indicating the potential of thisIntroduction
scaffold as an antibody mimetic. Subsequent affinity
maturation experiments yielded binders with dissocia-In the post-genomic era, truncated antibodies such as
Fab (fragment antigen binding) and scFv (single-chain tion constants as low as 20 pM, showing that nanomolar
binding constants are not an affinity ceiling for this scaf-fragment variable) antibody fragments, which have been
produced by display technologies, have been gaining fold [9].
To explore the potential of this scaffold further, weincreased use as tools for studying protein function.
Despite their utility, they are frequently hard to work with constructed a phage-displayed FN3 library of 2  109
individual clones, where the residues in the BC and FGdue to instability and low yields in bacterial expression
systems. In addition, the antibody fragments contain loops were diversified. Screening the library for binders
to the SH3 domain of the proto-oncogene c-Src, a non-disulfide bonds and generally do not fold properly when
expressed in the reducing environment of the cyto- receptor tyrosine kinase that plays a critical role in
eukaryotic signal transduction, yielded six different FN3plasm. Therefore, other proteins have been explored as
alternative scaffolds for use as antibody mimetics. (hereafter referred to as “monobody,” as coined by
Koide et al. [5]) clones [10]. Herein we report the analysisThese proteins offer a stable framework and solvent-
exposed residues responsible for ligand recognition, of these monobodies. Our work extends the utility of
this domain as a suitable scaffold for antibody mimetics.which can be randomized to confer novel binding acti-
vities to the parent molecule. Such scaffolds include
human cytotoxic T-lymphocyte associated protein-4
Results(CTLA-4) [1], Z domain of Staphylococcal protein A [2],
lipocalins [3], green fluorescent protein [4] (see Note
Isolation of Monobodies that Bind
to the Src SH3 Domain
We constructed an M13 phage library displaying FN3 in
which five residues in both the BC loop and the FG
loop were randomized. The library consisted of 2  109
Specificity and Affinity of the Monobodies
Binding affinity and specificity of the six different clones
were determined using two types of experiments. As
can be seen by phage ELISA (Figure 2A), binding was
specific to the Src SH3 domain, as the phage clones
bound neither streptavidin nor an unrelated biotinylated
protein (APC1336, an open reading frame of unknown
function from Bacillus subtilis), which carried the same
vector-encoded flanking peptide sequences as the Src
SH3 domain. All of the clones, except for 1E3, appeared
to have similar relative binding strengths to the Src SH3
domain. To examine whether the clones retained their
binding properties outside of the phage context, we then
tested these clones as N-terminal fusion proteins to a
highly active variant of the E. coli alkaline phosphatase
(AP) protein [11]. Because AP requires an oxidizing envi-
ronment for the correct formation of disulfide bonds
required for its stability and activity, the fusion con-
structs were expressed from a plasmid that includes
a periplasmic localizing signal peptide sequence. As
shown in an enzyme-linked binding assay (ELBA), the
six clones were confirmed to bind specifically to the
Src SH3 domain, but with somewhat differing bindingFigure 1. Schematic Drawing of FN3
strengths (Figure 2B). Thus, both the phage ELISA andThe seven  sheets that comprise the domain and the connecting
ELBA experiments showed that the binding of the mono-loops are labeled.
bodies selected from the library to their target is highly
specific.
individual clones and displayed the FN3 variants in a To determine the binding affinity of the monobodies,
monovalent fashion. The library was screened for bind- the dissociation constants of the strongest and weakest
ers to the SH3 domain of the human c-Src protein (Src binding proteins were measured by isothermal titration
SH3), which was biotinylated in vivo and immobilized calorimetry (ITC). Gene fragments encoding 1F11 and
on streptavidin-coated magnetic beads. After three 1C9 were cloned into an expression vector and purified
rounds of affinity selection, 192 clones were tested for to homogeneity. The purified proteins were dialyzed
binding to the Src SH3 domain: 22 were positive and thoroughly against PBS buffer and titrated into the sam-
DNA sequencing revealed six unique sequences (Table ple cell of an isothermal calorimeter containing the Src
1). The 1C9 clone was recovered 15 times, the 1F11 SH3 domain also in PBS buffer. A representative ITC
clone occurred three times, and the other four clones experiment between Src SH3 and 1F11 is shown in Fig-
were “singletons.” While the sequences of the BC loops ure 3. The dissociation constants were determined to
varied considerably between the clones, five of the six be 0.25 (0.02) M and 1.3 (0.1) M for 1F11 and 1C9
monobodies contained proline-rich sequences in their binding the Src SH3 domain, respectively. The number
randomized FG loop regions. Clone 1E3 differed from of binding sites (N) for 1F11 and 1C9 on Src SH3 was
the others by an FG loop sequence that was not proline- calculated to be approximately 1.0, as expected (N 
rich and contained a pair of cysteine residues. Four 0.977  0.009 for 1F11; N  1.035  0.021 for 1C9). No
clones (1C9, 1F11, 1F10, and 2G10) contained two nu- quantitative differences were observed in comparing the
cleotide deletions in the monobody framework, pre- binding of the two monobodies to either biotinylated or
ceding the FG loop, and one nucleotide deletion in the nonbiotinylated forms of the Src SH3 domain (data not
randomized region of the FG loop, which led to the shown).
restoration of the reading frame and alteration of one To determine the binding specificity of the monobod-
ies, 1F11 and 1E3 were examined for their binding toor two framework residues.
Table 1. Analysis of the Src SH3 Domain Binders
Consensus
Clone BC Loop FG Loop (RxxPxxP) Frequency Kd (M)
1C9 DAPSGPLDYYR A-YSLSPP—SKP LSPPSKP 15 1.3
1F11 DAPGISQGYYR A-YSRPLP—SKP RPLPSKP 3 0.25
1F10 DAPMALTAYYR A-YQRALP—SKP RALPSKP 1 ND
2G10 DAPRTPKHYYR -LYQLPLP—SKP LPLPSKP 1 ND
2B2 DAPCQHNLYYR AVTKRPLP—SKP RPLPSKP 1 ND
1E3 DAPFQTIQYYR AVTLCARC—SKP NA 1 ND
Wild-type DAPAVTVRYYR AVTGRGDSPASSKP NA – ND
Amino acid sequences in the predicted BC and FG loops of the FN3 monobodies are in bold, sequences surrounding the loops are underlined,
and dashes indicate deletions. Consensus amino acids in bold and underlined are essential and preferred, respectively, compared to the
optimal class I peptide ligand (RPLPPLP) of the SrcSH3 domain [14]. NA, not applicable; ND, not determined.
Figure 2. Analysis of the Anti-Src SH3 Monobodies
(A and B) (A), Phage ELISA; (B), ELBA. Assays were performed in duplicate for phage ELISA and triplicate for ELBA. Wells of microtiter plates
were coated with 400 ng (for ELISA) or 200 ng (for ELBA) of streptavidin. Two hundred nanograms (for ELISA) or 100 ng (for ELBA) of biotinylated
Src SH3 or an unrelated biotinylated protein expressed from the same plasmid as Src SH3 was immobilized in the wells. After blocking with
1% BSA, clonal phage supernatants or monobody-AP fusions were added to the wells for ELISA and ELBA, respectively. Binding was
colorimetrically detected by incubation with anti-M13 antibody-HRP conjugate, followed by addition of the HRP substrate, 2,2-azino-bis 3-
ethylbenzthiazoline-6-sulfonic acid, or by addition of the AP substrate, para-nitrophenyl phosphate. Streptavidin only (striped bars), control
protein (white bars), Src SH3 (black bars).
(C) Affinity of the anti-Src SH3 monobodies 1F11 and 1E3 for other SH3 domains. ELBA assays were performed using GST fusions of SH3
domains of either Src-family or unrelated proteins as antigen. Percent amino acid identities with the Src SH3 domain are as follows: Yes,
77%; Fyn, 76%; Lyn, 53%; Lck, 49%; Csk, 38%; Intersectin SH3-A, 30%; PLC	, 1 40%; Grb2-N, 34%; Spectrin , 1 31%; and p53BP2, 33%.
Assays were performed in triplicate using 100 ng of purified 1F11-AP or 1E3-AP per well.
(D) Contribution of BC and FG loops to target binding. ELBA with chimeric monobodies was performed as described for (B) using cell extracts,
in triplicate. Replacement of the BC loops with the wild-type FN3 sequences is denoted as “wt/FG,” and replacement of the FG loops with
the wild-type FN3 sequences is denoted as “BC/wt.”
an array of SH3 domains. ELBA experiments were per- selected monobodies carried proline-rich sequences in
their FG loops. The FG loop sequences of 1F11, 2B2,formed with SH3 domains of five other Src-family pro-
teins using purified AP-fusions of 1F11 (1F11-AP) and 1F10, 1C9, and 2G10 resemble the RPLPPLP consensus
identified from screening combinatorial peptide libraries1E3 (1E3-AP). 1F11-AP recognized glutathione-S-trans-
ferase (GST) fusions of SH3 domains of Yes, Fyn, Lyn, [14], with the R residue replaced by an L in 1C9 and
2G10. Furthermore, clones 1F11, 2B2, and 2G10 alsoLck, and n-Src, a form of Src that contains six additional
amino acids due to alternative splicing in neuronal tis- contained the preferred residues P and L in the second
and third position of the phage-display-derived con-sues [12], although the binding was significantly weaker
in comparison to Src SH3 (Figure 2C). 1E3-AP bound sensus.
The similarity of the FG loop sequences with the Srconly to the Src SH3 domain (Figure 2C). Both monobod-
ies failed to bind to SH3 domains of six other proteins SH3 domain peptide ligands suggested that five of the
monobodies bind the Src SH3 domain at the same place.that do not belong to this family (i.e., Csk, Intersectin,
PLC	1, Grb2, Spectrin, and p53BP2), demonstrating To validate this, we examined whether soluble forms of
that their binding is specific to the SH3 domains of Src the 1F11 monobody could inhibit binding of an enzyme-
and/or its family members (Figure 2C). linked peptide ligand (i.e., RPLPPLP) to the Src SH3
domain. Figure 4A demonstrates that the 1F11 mono-
body was able to block the binding of the peptide ligandAnalysis of the Binding Site of the Monobodies
on the Src SH3 Domain to the Src SH3 domain, whereas the wild-type protein
did not, indicating that 1F11 binds at or near the sameSH3 domains are known to bind proline-rich sequences
[13], and thus it is not surprising that five of the six region as the peptide ligand. Based on the high similarity
Figure 3. Measurement of the Kd between Src SH3 and the High-
Affinity Monobody by ITC
Representative ITC experiment performed using Src SH3 and the
monobody 1F11. The top panel shows the raw data: the heat flow
generated as a result of injections of a solution of 1F11 in PBS into
a solution of Src SH3 also in PBS in the sample cell. Each peak
represents a single injection. The bottom panel shows the binding
isotherm created by plotting the integrated heats against the molar
ratio between the two proteins.
Figure 4. Competitive Binding Assays
(A) Competition between Src SH3 peptide ligand and 1F11 for Src
of the FG loop sequences of monobodies 2B2, 1F10, SH3 binding. Purified Src SH3 peptide ligand-AP fusion was used to
detect immobilized Src SH3 in an ELBA as described in Experimental1C9, 2G10, and 1F11, we believe that they bind the Src
Procedures. For competition, increasing amounts of purified 1F11SH3 domain in a comparable manner.
(squares) or wild-type FN3 (circles) were combined with peptideSince the 1E3 monobody lacks a proline-rich FG loop,
ligand-AP fusion during the binding step.
it was possible that this monobody bound at a unique (B) Competition between 1F11 and 1E3 for Src SH3 binding. Binding
site on the Src SH3 domain other than the peptide bind- of 1F11-AP fusion to immobilized Src SH3 was determined in the
ing groove. To determine whether 1E3 and 1F11 bind presence of increasing amounts of purified 1F11 (closed squares)
or wild-type FN3 (closed circles). Binding of 1E3-AP fusion wasat the same or different sites, we performed competition
determined in the presence of increasing amounts of purified 1F11experiments: 1F11-AP or 1E3-AP were mixed with in-
(open squares) or wild-type FN3 (open circles).creasing amounts of soluble wild-type protein or 1F11
monobody and incubated with Src SH3 domain immobi-
lized in a microtiter plate well. As expected, 1F11-AP ple, and thus signals from unlabeled monobodies and
peptide are eliminated [15, 16]). In addition to the twobinding was inhibited by addition of soluble 1F11,
whereas addition of the wild-type monobody had no monobodies, we also used a high-affinity peptide for
Src SH3, VSLARRPLPPLP, as a control [17].effect on the binding of either 1F11-AP or 1E3-AP (Figure
4B). To our surprise, 1E3-AP binding was also inhibited The profile of chemical shift perturbation (Figure 5)
caused by the binding of 1F11 monobody was similareffectively with the addition of soluble 1F11 (Figure 4B),
demonstrating that binding of 1F11 and 1E3 monobod- to that of the high-affinity peptide, confirming that 1F11
binds to the proline-rich peptide binding site. The af-ies to the Src SH3 domain are mutually exclusive.
We further investigated the binding site of the 1E3 fected residues are mainly localized near the peptide
binding interface of the SH3 domain (Figure 5). We couldand 1F11 monobodies using heteronuclear NMR spec-
troscopy. We prepared 15N-labeled Src SH3 domain and not detect any signs of binding of the 1E3 monobody
when we initially performed NMR measurements in thecompleted sequence-specific assignments of back-
bone 1H and 15N resonances. Perturbation of amide 1H absence of a reducing reagent (data not shown); how-
ever, the SH3 spectrum changed when we repeated theand 15N resonances of the SH3 domain was monitored by
comparing the 1H, 15N-HSQC spectrum of the 15N-labeled measurements in the presence of dithiothreitol. As the
1E3 monobody contains two cysteine residues in the FGSH3 domain in the presence and absence of a binding
partner. (Note that this experiment selectively measures loop, this last observation suggests that these cysteines
are in the reduced form in the active state of this mono-signals from a 15N-labeled component in an NMR sam-
Figure 5. Analysis of the Binding Sites on Src
SH3
Perturbation of NMR peak positions of the
Src SH3 domain by binding of a high-affinity
peptide (a), the 1F11 (b), and 1E3 (c) mono-
bodies. The perturbation values (see Experi-
mental Procedures) are plotted as a function
of SH3 residue number. The residue number-
ing is according to Protein Data Bank entry
1QWF [17]. The four residues designated with
an arrow in (a) had values greater than 35.
SH3 residues affected by binding are mapped
graphically on the right using PyMol software
(www.delanoscientific.com). The amide nitro-
gen positions of residues exhibiting pertur-
bation values greater than 2.5 (light pink), 5
(pink), and 10 (red) are shown as spheres in
the structure of Src SH3 domain (blue) in
complex with a high-affinity peptide (white),
VSLARRPLPPLP (Protein Data Bank ID code
1QWF) [17]. Residues that showed significant
perturbation but have solvent-accessible sur-
face areas less than 10 Å2 have been ex-
cluded, because perturbation of such resi-
dues is likely due to indirect effects. Note that
residues 5–7 and 67–72 (residue numbering
according to 1QWF) are all affected by 1E3 binding, but are not included in the figure because these residues are missing in the structure.
The structure corresponds to residues 9–65. The N and C termini of the SH3 domain are marked in the figure.
body. The perturbation profile of 1E3 was distinctly dif- Utility of the Monobodies
As we wanted to clarify whether we could use the engi-ferent from those of the peptide and 1F11 (Figure 5). In
particular, residues between 50 and 60 were not affected neered monobodies as affinity reagents, the strongest
binder, 1F11, was tested in Western blotting and pull-by 1E3 binding, while residues close to the N and C
termini were more affected by 1E3 binding than by the down experiments. Ten micrograms of purified GST,
GST-Src SH3, GST-Yes SH3, and GST-Intersectin SH3others tested here. The distribution of SH3 residues af-
fected by 1E3 binding (Figure 5) is clearly different from were resolved by SDS-PAGE, blotted onto nitrocellu-
lose, incubated with 1F11-AP, and protein complexesthose affected by the peptide or by 1F11. (Note that the
atomic coordinates used for Figure 5 do not contain were detected by chemiluminescence (Figure 6A). 1F11-
AP bound to the filter-blotted Src SH3 domain with littleresidues near the termini that were affected by 1E3 bind-
ing, and thus these residues are not included.) Thus, or no binding to the other blotted proteins, despite the
large amounts of protein present. Some binding to Yesthe NMR data strongly indicate that 1E3 binds to a site
that is somewhat different from the peptide binding cleft. SH3 was detected with increasing incubation times
(data not shown). However, 1F11-AP was unable to de-The results also suggest a partial overlap of the binding
epitopes for 1F11 and 1E3, which can explain the mu- tect full-length c-Src in extracts of A431 cells in Western
blot (data not shown); presumably, its affinity was nottually exclusive binding of these two monobodies to
Src SH3. high enough for detecting small amounts of c-Src pres-
ent on the blot.
Next, we determined whether 1F11 could be used toContribution of the BC and FG Loops
pull down full-length c-Src from mammalian cell ex-to Target Binding
tracts. Soluble forms of the wild-type and 1F11 mono-To determine to what extent each of the randomized
bodies were immobilized on Ni-NTA agarose beads andloops contribute to binding, we swapped each of the
incubated with cell extracts of a mouse fibroblast cellloop sequences in the monobodies with those of the
line expressing c-Src. As seen in Figure 6B, beadswild-type monobody and compared the relative binding
loaded with 1F11 recovered full-length c-Src from a cellstrengths of the chimeric proteins to the Src SH3 do-
extract, while wild-type FN3 (or beads alone) did not,main. Replacing the FG loop with the wild-type se-
demonstrating that the monobodies can be used suc-quence completely abolished binding of the 1F11 mono-
cessfully in pull-down experiments.body to the Src SH3 domain (Figure 2D), as anticipated
because of the high level of similarity of the FG loop
sequence to the peptide ligand. Surprisingly, replacing Discussion
the BC loop with the wild-type sequence also diminished
binding of 1F11 to the Src SH3 domain (Figure 2D). From a phage-displayed library of FN3 domains, in
which a total of ten amino acids were randomized onA similar result was observed with the two chimeric
constructs of 1E3. These observations suggest that both two-surface exposed loops, we successfully isolated
affinity reagents for the SH3 domain of the human onco-loops contribute to the interaction between the Src SH3
domain and the selected monobodies. genic protein, c-Src. Twenty-two positive clones, corre-
ies, the positive charge of the class I motif has been
replaced by a leucine, which in one case (clone 1C9)
led to a reduction in binding strength as expected; how-
ever, in another case (clone 2G10) binding strength was
unaltered. This is somewhat surprising, given that the
positively charged residue in the peptide ligand se-
quence contributes significantly to binding.
Mutagenesis experiments have confirmed that in two
of the clones tested (1F11 and 1E3), both of the random-
ized loops contributed significantly to binding. In the
case of 1F11, this was unexpected. Since the entire
proline-rich binding motif is contained in the FG loop,
replacing the BC loop with the wild-type BC loop se-
quence was not expected to cause a drastic reduction
in the binding affinity of this clone to Src SH3. These
results indicate that there are determinants for binding
the Src SH3 domain in both loops, and that the BC loop
either directly takes part in the intermolecular interaction
with the Src SH3 domain or stabilizes the binding indi-
rectly through intramolecular interactions. Given that, in
the three-dimensional structure of FN3, the BC and FG
loops are located adjacent to each other, both of these
explanations are plausible [23]. This observation also
agrees with analysis of an engineered monobody that
binds ubiquitin [5], in which alanine replacement of each
residue in the randomized loops led to a reduction in
binding to ubiquitin. Further structural analysis of mono-
body-SH3 complexes will reveal the exact nature of
these interactions.
Analysis of selected monobodies showed that they
Figure 6. Utility of the Monobody in Western Blots and Pull-Down bound the target with modest affinity. By isothermal
Assays titration calorimetry, the dissociation constants for the
(A) Western blot. Ten micrograms of each of the proteins (GST or weakest (1C9) and strongest (1F11) binders to the Src
GST fusions to the SH3 domains of Src, Yes, or Intersectin) was SH3 domain are estimated to be 1.3 and 0.25 M, re-
separated by SDS-PAGE on two gels. One was stained with Coo- spectively. Such measurements paralleled the differ-
massie blue (top gel); the other was used for Western blotting (bot-
ences in binding of AP fusion proteins for the two bind-tom gel) with a 100 ng/ml solution of purified 1F11-AP protein.
ers, rather than the phage ELISA measurements,(B) Pull-down. Cellular Src protein was isolated from cell extracts
suggesting that the ELBAs are more representative ofof mouse embryonic stem cells using 1F11. Assay was performed
as described in Experimental Procedures using Ni-NTA agarose binding strength. The ability of the monobody scaffold
beads alone (lane 1), loaded with 1F11 (lane 2), or loaded with wild- to yield high-affinity reagents has been demonstrated
type FN3 (lane 3). Beads were washed, boiled, and subjected to by Xu and coworkers [9], who isolated binders from an
SDS-PAGE followed by Western blotting with a mouse monoclonal
mRNA display library that bound TNF- and leptin withanti-Src antibody GD11.
nanomolar dissociation constants. The complexity of
our library was approximately three orders of magnitude
sponding to six unique sequences, were isolated from smaller than this mRNA display library. We suspect that
a library of two billion recombinants after three rounds of larger phage-displayed libraries may yield tighter affinity
affinity selection. Interestingly, five out of the six unique reagents, as there is a direct correlation between the
clones had proline-rich FG loop sequences that resem- size of the display libraries and the affinity of the binders
bled the class I peptide ligand sequence preference isolated from said libraries [24]. In addition, since both
(i.e., xxPxxP) of the Src SH3 domain. It is generally loops in the monobodies contribute to binding, it will
agreed that proteins have a limited number of regions take large libraries to find their optimal sequence contri-
for interaction with other proteins. Such binding sites bution. Nevertheless, the affinities of the selected mono-
have been termed “hot spots” [18] in which a small bodies are stronger than that of peptides (i.e., 3 M)
number of amino acids, typically hydrophobic and disor- and are comparable to natural interacting partners. For
dered, contribute the bulk of the binding energy. The example, the HIV Nef protein binds the Hck SH3 domain
hot spot of most SH3 domains consists of two shallow with a Kd of 250 nM [25]. Despite their modest affinity,
pockets that accommodate each proline in the PxxP the strongest monobody was suitable for displacing nat-
motif and a third pocket that seats the positively charged ural interacting partners of the SH3 domain in pull-down
residue in the xxPxxP or PxxPx motif of class I or experiments. The monobodies also showed excellent
class II ligands, respectively [19, 20]. Thus, the majority specificity for their targets. Neither of the two monobod-
of the monobodies appear to “home in” on the same ies tested bound non-Src family SH3 domains, although
hot spot of the SH3 domain, as do combinatorial pep- the 1F11 clone did bind somewhat to SH3 domains from
other members of the Src family of tyrosine kinases. Ontides [14, 19, 21, 22]. In the case of two of the monobod-
Experimental Proceduresthe other hand, clone 1E3 was highly specific for the
Src SH3 domain. This is a level of specificity that has
Reagentsbeen difficult to achieve with combinatorial peptide li-
The E. coli strains TG1 and BL21(DE3) (Novagen, Madison, WI) were
gands [26]. Therefore, these monobodies can potentially used for plasmid propagation and protein expression, respectively.
be used for selective detection, coimmunoprecipitation, All restriction endonucleases and DNA modification enzymes except
for T4 DNA Ligase (Promega, Madison, WI) were from New Englandor intracellular perturbation of c-Src and some of its
BioLabs (Beverly, MA). Pfu Turbo DNA Polymerase was from Stra-family members.
tagene (La Jolla, CA). The phagemid pHEN4::cAbLys3 was a giftSince their introduction by Koide and coworkers, the
of Dr. Serge Muyldermans (Vrje Universieit, Belgium). The plasmidpotential of monobodies to yield useful reagents has
containing the coding sequence for APC1336 was a gift from Dr.
been explored briefly by only two previous studies. In Frank Collart (Argonne National Laboratory, Argonne, IL). T24E
the first, monobodies specific for agonist- or antagonist- mouse embryonic fibroblasts were a gift from Dr. Marsha Rosner
(University of Chicago, Chicago, IL). The mouse monoclonal anti-bound forms of the estrogen receptor have been used
Src antibody GD11, goat anti-mouse HRP-conjugate, and A431 cellto probe the conformational state of this protein in yeast
extracts were obtained from Upstate (Lake Placid, New York). 2,2-cells by Koide and coworkers [8]. In the second, high-
Azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) was fromaffinity binders have been isolated against TNF- and
Sigma (St. Louis, MO). HRP-conjugated anti-M13 antibody was from
leptin by Xu and coworkers [9], which were subsequently Amersham Biosciences (Piscataway, NJ). DNA sequencing and oli-
used to construct self-assembling protein arrays. We gonucleotide synthesis were performed by MWG Biotech (High
Point, NC).have explored the potential of this scaffold further to
show that it can be used for pull-down experiments as
soluble protein and for binding assays as a fusion to FN3 Gene Construction
AP. We have also shown that monobodies can yield The human fibronectin tenth type III domain (FN3) gene was con-
structed essentially as described by Koide et al. [5], with severalvery specific binders for proteins with a high degree of
modifications. Briefly, six oligonucleotides, approximately 60 basessimilarity, such as the SH3 domains used in this study.
each, with 16 nucleotides of complementarity at their 5 and 3Because one of the monobodies was able to bind
termini were assembled into double-stranded DNA with the Klenowthe full-length c-Src, it can potentially be used as an
fragment of the E. coli DNA polymerase. The product was amplified
intrabody for selective intracellular manipulation of by PCR using Pfu DNA polymerase and cloned into pBluescript SK
c-Src. Furthermore, AP or green fluorescent protein fu- (Stratagene). To maximize expression of the FN3 domain in E. coli,
the coding region was designed with codons frequently used insions of these monobodies can be used for colorimetric
E. coli. Also, a D7K mutation was incorporated to increase stabilityand fluorescence detection and/or localization of their
of the FN3 domain at neutral pH [27]. The assembled FN3 openrespective antigens. In the future, it should be possible
reading frame was then amplified by PCR with two sets of primers,to select highly specific reagents for other SH3 domains
denatured and annealed to generate heteroduplexes with sticky
as well either from this library or from other focused ends, and cloned into the phagemid vector, pHEN4 [28], as a fusion
libraries that can be constructed with this scaffold. to gene III of bacteriophage M13. This construct, pHEN4::FN3, was
confirmed by sequencing and transformed into TG-1 cells for viral
packaging with the helper virus, M13K07. Display of wild-type FN3Significance
on the phagemid particles was confirmed by ELISA with a polyclonal
anti-fibronectin antibody from Sigma (St. Louis, MO).The utility of the monobody, as an antibody mimetic
based on the tenth type III domain of human fibronec-
Library Constructiontin, was demonstrated with the isolation of two classes
A library was constructed that randomized five codons in both theof monobodies that bound to the SH3 domain of the
BC (residues 26–30) and FG loops (residues 77–81) coding regionshuman oncogenic protein, c-Src. One class contained
and contained a three amino acid deletion in the FG loop, similar
proline-rich sequences similar to class I peptide li- to that previously reported [5]. NNK codons were used to randomize
gands for Src SH3 and bound at the peptide binding the ten positions, where N is an equimolar mixture of all nucleotides,
and K is an equimolar mixture of G and T. This codon set encodespocket, as shown by competitive binding and NMR
all of the amino acids and one stop (TAG) codon that is suppressedperturbation experiments. The second class, which
in TG1 cells by the supE gene product by the insertion of glutamine.contained only one member, lacked proline-rich se-
Briefly, the FN3 coding region was amplified in two halves, usingquences and bound Src SH3 at a site somewhat sepa-
primers P1 (forward) and P2 (reverse) for the N-terminal half and P3
rate from the peptide binding site. The first class of (forward) and P4 (reverse) for the C-terminal half of the protein. (P1
monobodies bound to the SH3 domain of other mem- anneals to a region in the vector upstream of the cloned FN3 gene.
bers of the Src family, and the second class was highly P2 encodes a 15-base NNK stretch flanked by 25 nucleotides com-
plementary to the FN3 gene on either side of the region encodingspecific and bound only to the SH3 domain of Src.
the BC loop. P3 is complementary to the 25 nucleotides at the 5The strongest binder had a dissociation constant of
end of P2. P4 is similar to P2, except that it anneals to the region0.25 M for Src SH3, which is comparable to the affinity
encoding the FG loop.) The resulting fragments were gel purified
of an SH3 domain with its cellular interacting partner. and assembled through overlap PCR, making use of the 25 nucleo-
The utility of the best monobody was evidenced by its tide long complementarity in their sequence. The resulting full-
ability to pull down c-Src from murine fibroblast cell length, randomized gene was gel purified yielding 130 ng of DNA
(2.6  1011 molecules), amplified a few cycles with another set prim-extracts, demonstrating that monobodies can be used
ers to yield sticky ends as described elsewhere [29], purified usingin coimmunoprecipitation experiments. In the future,
the Qiagen PCR product purification kit (Valencia, CA), and ligatedhighly specific monobodies like the ones isolated here
into NcoI/NotI-digested pHEN4. This material was transformed bycould be expressed inside cells to interfere with pro-
electroporation into E. coli TG1 cells. The library size was determined
tein function and thus serve as a valuable tool to study to be 2  109 individual clones, with a vector background of 0.1%.
protein function. Our work supports the use of mono- For affinity selection experiments, the library of FN3 plasmids was
rescued with the helper phage M13K07, and the resulting viral parti-bodies as affinity reagents in research and diagnostics.
cles were concentrated by precipitation with a final concentration Binding assays for the monobody-AP fusions were performed
with 96-well microtiter plates that had been coated with 200 ng ofof 6% polyethylene glycol and 0.3 M NaCl.
streptavidin and 100 ng of biotinylated Src SH3 domain. In some
cases, 1 g of glutathione-S-transferase (GST) fusions to differentTarget Preparation and Affinity Selection Experiments
SH3 domains was immobilized directly in the wells. Monobody-APThe human c-Src SH3 domain coding region was amplified by PCR
fusions were added either as purified proteins at 100 ng/well or asand cloned into the expression vector pMSCG16 [39] using ligation
extracts of bacterial cells lysed with Bugbuster detergent (Novagen).independent cloning (LIC) [30]. This vector encodes an N-terminal
Cell extracts were prepared as follows. Two milliliters of culturessix-histidine tag, a substrate sequence (AviTag) for biotin ligase [31],
were grown overnight in LB, cells were recovered by centrifugation,a GSGS linker, a cleavage site for the tobacco etch virus (TEV)
and the pellets were resuspended in 100 l of Bugbuster reagentprotease, and an LIC site. This construct was transformed into the
with 0.1 l of Benzonase (Novagen). After 30 min incubation at 25
C,E. coli strain BL21 (DE3) (Novagen) carrying the pBIRAcm plasmid
cell debris was pelleted by centrifugation for 15 min. AP activity in(Avidity, Denver, CO). This plasmid encodes the biotin ligase re-
the supernatant was measured and normalized. Approximatelyquired for in vivo biotinylation of the target protein. Expression of
1–3 l of the supernatant was used per well, and bound enzymethe SrcSH3 domain was induced at an optical density (600 nm
was detected with the chromogenic substrate para-nitrophenylpho-wavelength) of 0.7 with 1 mM IPTG for 5 hr at 30
C; at the time of
sphate (Sigma). For competition experiments, either the peptideIPTG addition, the cells were also supplemented with 50 M D-biotin
ligand-AP fusion or monobody-AP fusions were mixed with different(Sigma). Cells were harvested and the Src SH3 domain was purified
amounts of purified soluble monobody before addition to the wells.using Ni-NTA resin (Qiagen) according to manufacturer’s instruc-
All experiments were performed in triplicate, and averages of thetions. Biotinylation was confirmed by binding to streptavidin-coated
data points were plotted.magnetic Dynabeads M-280 (Dynal Biotech, Lake Success, NY).
Affinity selection experiments were performed using 100 nM Src
SH3 on streptavidin-coated magnetic beads as follows. One milliliter Cellular Expression and Purification of FN3
of the library, containing 1012 phagemid particles, was precleared To generate soluble protein for competition, ITC, and NMR experi-
on 100 l Dynabeads and then incubated with the biotinylated target ments, genes encoding the monobodies and the wild-type FN3 were
on the beads at room temperature (with tumbling) for 2 hr. Beads cloned into pET28 (b) (Novagen), an intracellular expression vector
were washed three times with 1 ml Tris-buffered saline (TBS: 50 mM that adds a six-histidine tag to the C terminus of the protein. For
Tris-HCl, 150 mM NaCl [pH 7.4]) containing 0.05% Tween-20 (TBST). competition and ITC experiments, cells were grown in LB, and pro-
Bound phage were eluted with 500 l of 50 mM glycine-HCl (pH 2) tein expression was induced, at an OD600 of 0.7, with 1 mM isopropyl-
and neutralized with 100 l of 1 M Tris-HCl (pH 8). Three hundred -D-thiogalactopyranoside (IPTG) for 16 hr at 30
C. Proteins were
microliters was used to infect exponentially growing TG1 E. coli purified by immobilized metal affinity chromatography using Ni-NTA
cells by incubation with gentle shaking at 37
C for 1 hr. Cells were beads (Qiagen), according to the manufacturer’s instructions. Puri-
plated on 2YT plates supplemented with 50 g/ml carbenocillin fied proteins were analyzed for quantity, molecular weight, and pu-
and 1% glucose (2YT-AG) and incubated overnight at 30
C. The rity using a BioAnalyzer 2100 (Agilent, Palo Alto, CA). Protein yields
next day, colonies were scraped into 5 ml 2YT, 200 l (6  109 were typically 100–200 mg per liter of culture.
cells) of which was inoculated into 10 ml 2YT-AG liquid medium,
grown for 1 hr at 30
C, and infected with 6  109 helper phage,
Isothermal Titration CalorimetryM13K07. After an additional hour of incubation at 37
C, the cells
Isothermal titration calorimetry (ITC) was performed at 30
C usingwere pelleted and resuspended in 10 ml 2YT with 50 g/ml carbe-
a VP-ITC (MicroCal, Northampton, MA). F11, C9, and Src SH3 werenocillin and 25 g/ml kanamycin. After overnight growth at 30
C,
purified as described above and dialyzed thoroughly against PBScells were pelleted by centrifugation, and the phage was precipi-
to ensure equivalent pH and salt concentration of the samples.tated from the supernatant in 6% polyethylene glycol-0.3 M NaCl
Proteins were filtered to remove any aggregates and degassed priorand resuspended in 500 l phosphate-buffered saline (PBS: 137 mM
to use. Src SH3 (30 M, 1.4 ml) was placed in the calorimetric cell,NaCl, 3 mM KCl, 8 mM Na2HPO4, 1.5 mM KH2PO4). One hundred
and F11 or C9 (300 M, 0.4 ml) was placed in the titration syringe.microliters of this material was used for the second round of selec-
Titration was conducted with injection of 3 l aliquots each, at ation, as described above.
default injection rate of 300 s intervals. The heat of associationAfter the third round of selection, cells were plated at limiting
was calculated from the difference between the integrated heat ofdilution, and 192 colonies were picked for verification of binding by
reaction and the corresponding heat of dilution. Data were analyzedphage ELISA. Biotinylated Src SH3 (200 ng) was immobilized in 96
using the Origin software (version 7.0), with embedded calorimetricmicrotiter plate wells that were coated with 400 ng of streptavidin
fitting routines, to determine N (number of binding sites), H (changeper well. The control for the initial screen consisted of streptavidin-
in binding enthalpy, cal/mole), S (change in binding entropy, cal/coated plates only. The positive clones were confirmed in duplicate
mole/deg), and Kd (dissociation constant).by a second phage ELISA, which included an unrelated biotinylated
protein (i.e., APC1336) as a negative control.
NMR Spectroscopy
15N-labeled Src SH3 protein was prepared by growing the expressionConstruction of Alkaline Phosphatase Fusions and Their Use
in Enzyme-Linked Binding Assays strain in M9 minimal media supplemented with 15N-ammonium chlo-
ride as the sole nitrogen source. The protein was purified as de-The regions encoding the six unique Src SH3 binding monobodies
were amplified using Pfu DNA polymerase and cloned into the alka- scribed above, and the N-terminal tag was cleaved off with TEV
protease, which itself contained a six-histidine tag. The uncleavedline phosphatase (AP)-fusion vector, pEZ707 [11], by LIC. This vector
allows expression and export of proteins into the periplasmic space protein, tag, and protease were removed by IMAC. The cleaved
protein was concentrated and buffer exchanged into 50 mM sodiumas N-terminal fusions to AP, which carries six histidines at the
C terminus for rapid purification by immobilized metal affinity chro- phosphate buffer (pH 6.0) containing 150 mM NaCl and 10 M EDTA
in 95% H2O/5% D2O using an Amicon ultrafiltration cell (Millipore,matography (IMAC). The AP protein encoded by this construct is a
variant carrying two mutations (D153G/D330N), which is approxi- Billerica, MA). The final protein concentration was 1.2 mM. 1H,
15N-HSQC, 15N-edited TOCSY, and 15N-edited NOESY [32, 33] weremately 16 times more active than the wild-type enzyme [11]. Be-
cause the BL21 (DE3) strain does not contain a supE gene, the TAG performed on a Varian INOVA 600 spectrometer using pulse se-
quences in the BIOPACK supplied by Varian. The HSQC spectra forcodons in 1F10, 1E3, 2G10, and 2B2 were converted to CAG, which
codes for glutamine, by site-directed mutagenesis. For purification chemical shift perturbation analysis were recorded on 0.2 mM
15N-labeled Src SH3 samples that contain 30% molar excess of aof the monobody-AP fusion proteins, cultures were grown in LB at
30
C until they reached an optical density of 0.7 and induced by binding partner. For measurements of the Src SH3-1E3 complex,
experiments were performed in the presence and absence of 5 mM0.5 mM IPTG and grown overnight at 30
C. Six-histidine-tagged
proteins were purified from whole-cell extracts, following Qiagen’s dithiothreitol. NMR data were processed using the NMRPipe suite
[34] and analyzed using the NMRView program [35] on a Linuxinstructions.
workstation. Backbone resonance assignments of Src SH3 were References
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